Removal of uremic toxins by renal replacement therapies: a review of current progress and future perspectives
Suguru Yamamoto(University of Niigata Prefecture), Ichiei Narita(Niigata University), Junichiro James Kazama(Japanese Society for Dialysis Therapy), Yoshikatsu Kaneko(Niigata University Medical and Dental Hospital), Takuya Wakamatsu(Niigata University Medical and Dental Hospital), Yoshimitsu Takahashi(Niigata University), Shin Goto(Niigata University Medical and Dental Hospital)
Cited by 65
Related Papers
CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis.
|American Journal of Roentgenology|1997|296
Dysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis
|Journal of the American College of Cardiology|2012|205
Overview of Regular Dialysis Treatment in <scp>J</scp>apan (as of 31 <scp>D</scp>ecember 2011)
|Therapeutic Apheresis and Dialysis|2013|198
Low Concentrations of Sodium Dodecyl Sulfate Induce the Extension of β<sub>2</sub>-Microglobulin-Related Amyloid Fibrils at a Neutral pH
|Biochemistry|2004|181
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
|Renal Replacement Therapy|2020|170